Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y)

A. C. Hepburn*, R. E. Steele, R. Veeratterapillay, L. Wilson, E. E. Kounatidou, A. Barnard, P. Berry, J. R. Cassidy, M. Moad, A. El-Sherif, L. Gaughan, I. G. Mills, C. N. Robson, R. Heer

*Corresponding author for this work

Research output: Contribution to journalComment/debate

26 Downloads (Pure)

Abstract


Original languageEnglish
Article number4425
JournalOncogene
Volume38
DOIs
Publication statusPublished - 08 May 2019

Fingerprint

Oncogenes
Neoplasms

Cite this

Hepburn, A. C. ; Steele, R. E. ; Veeratterapillay, R. ; Wilson, L. ; Kounatidou, E. E. ; Barnard, A. ; Berry, P. ; Cassidy, J. R. ; Moad, M. ; El-Sherif, A. ; Gaughan, L. ; Mills, I. G. ; Robson, C. N. ; Heer, R. / Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y). In: Oncogene. 2019 ; Vol. 38.
@article{5ed25e384ff24d2bb913be1a34520aff,
title = "Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y)",
author = "Hepburn, {A. C.} and Steele, {R. E.} and R. Veeratterapillay and L. Wilson and Kounatidou, {E. E.} and A. Barnard and P. Berry and Cassidy, {J. R.} and M. Moad and A. El-Sherif and L. Gaughan and Mills, {I. G.} and Robson, {C. N.} and R. Heer",
year = "2019",
month = "5",
day = "8",
doi = "10.1038/s41388-019-0826-2",
language = "English",
volume = "38",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",

}

Hepburn, AC, Steele, RE, Veeratterapillay, R, Wilson, L, Kounatidou, EE, Barnard, A, Berry, P, Cassidy, JR, Moad, M, El-Sherif, A, Gaughan, L, Mills, IG, Robson, CN & Heer, R 2019, 'Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y)', Oncogene, vol. 38, 4425. https://doi.org/10.1038/s41388-019-0826-2

Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y). / Hepburn, A. C.; Steele, R. E.; Veeratterapillay, R.; Wilson, L.; Kounatidou, E. E.; Barnard, A.; Berry, P.; Cassidy, J. R.; Moad, M.; El-Sherif, A.; Gaughan, L.; Mills, I. G.; Robson, C. N.; Heer, R.

In: Oncogene, Vol. 38, 4425, 08.05.2019.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y)

AU - Hepburn, A. C.

AU - Steele, R. E.

AU - Veeratterapillay, R.

AU - Wilson, L.

AU - Kounatidou, E. E.

AU - Barnard, A.

AU - Berry, P.

AU - Cassidy, J. R.

AU - Moad, M.

AU - El-Sherif, A.

AU - Gaughan, L.

AU - Mills, I. G.

AU - Robson, C. N.

AU - Heer, R.

PY - 2019/5/8

Y1 - 2019/5/8

U2 - 10.1038/s41388-019-0826-2

DO - 10.1038/s41388-019-0826-2

M3 - Comment/debate

AN - SCOPUS:85065537017

VL - 38

JO - Oncogene

JF - Oncogene

SN - 0950-9232

M1 - 4425

ER -